PETROPAVLOVSK-KAMCHATSKY, Russia (Sputnik) - Russia’s Vector research centre plans to release two variants of a COVID-19 vaccine into circulation, said director of the centre Rinat Maksyutov.
PETROPAVLOVSK-KAMCHATSKY, Russia (Sputnik) - Russia’s Vector research centre plans to release two variants of a COVID-19 vaccine into circulation, said director of the centre Rinat Maksyutov.
PETROPAVLOVSK-KAMCHATSKY, Russia (Sputnik) - Russia’s Vector research centre plans to release two variants of a COVID-19 vaccine into circulation, said director of the centre Rinat Maksyutov.
PETROPAVLOVSK-KAMCHATSKY, Russia (Sputnik) - Russia’s Vector research centre plans to release two variants of a COVID-19 vaccine into circulation, said director of the centre Rinat Maksyutov.
MOSCOW (Sputnik) - Alexander Gintsburg, the director of Russia’s Gamaleya Institute, which developed the first registered COVID-19 vaccine, told Sputnik on Friday that patients show adequate lev
MOSCOW (Sputnik) - Alexander Gintsburg, the director of Russia’s Gamaleya Institute, which developed the first registered COVID-19 vaccine, told Sputnik on Friday that patients show adequate lev
MOSCOW (Sputnik) - Alexander Gintsburg, the director of Russia’s Gamaleya Institute, which developed the first registered COVID-19 vaccine, told Sputnik on Friday that patients show adequate lev
MOSCOW (Sputnik) - Alexander Gintsburg, the director of Russia’s Gamaleya Institute, which developed the first registered COVID-19 vaccine, told Sputnik on Friday that patients show adequate lev
MOSCOW (Sputnik) - Alexander Gintsburg, the director of Russia’s Gamaleya Institute, which developed the first registered COVID-19 vaccine, told Sputnik on Friday that patients show adequate lev
MOSCOW (Sputnik) - The Russian biotechnology company Biocad told Sputnik on Thursday that it would produce the COVID-19 vaccine developed by Russia's Gamaleya research centre and was also set to
